Title : [Correlation of Her-2 overexpression with endocrine status and response to tamoxifen treatment in patients with breast cancer].

Pub. Date : 2007 Dec 11

PMID : 18396622






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 (2) The general 3-year disease-free survival (DFS) rate of those treated with TAM was 92.7%; and the 3-year GFS rate of the subgroup of the TAM-treated patients with Her-1 overexpression was 91.2%, significantly lower than that of those without Her-2 overexpression (93.4%, P = 0.004). Tamoxifen epidermal growth factor receptor Homo sapiens